// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Using parasternal electromyogram to measure neural respiratory drive in pulmonary hypertension

Paul Mccaughey - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary arterial hypertension

N/A

Sex bias exists in diagnosing pulmonary arterial hypertension via machine learning

Johanna Uthoff - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Cardiopulmonary exercise test unveils abnormal exercise physiology in patients affected by pulmonary arterial hypertension with a low-risk profile 6 minute walk distance

Beatrice Vigo - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Pulmonary arterial hypertension

N/A

Pulmonary artery endothelial cell exposure to hepcidin affects BMP-signalling; relevance to vascular remodelling in PAH

Ioannis Panselinas - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Is cardiac output assessed by inert gas rebreathing technique predictive of mortality in pulmonary hypertension?

Lucy Robertson - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Perioperative management of patients with Pulmonary Hypertension undergoing Non-Cardiac Surgery: A Systemic Review and UK Consensus Statement

Laura Price - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

Hydroxyzine

Improvements in the dysfunctional right ventricle with Macitentan treatment in a sugen/hypoxic rat model of pulmonary hypertension

Gerard Murphy - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

macitentan

A Minimal Clinically Important Difference for CAMPHOR in Idiopathic Pulmonary Arterial Hypertension

Katherine Bunclark - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

camphor

Lung perfusion in pulmonary hypertension – results from the RESPIRE study

Paul Hughes - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Cardiac MRI right atrial area measurement thresholds for risk stratification in patients with PAH

Faisal Alandejani - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Serial cardiac MRI for assessment of cardiac morphology and function in CTEPH patients after PEA or vasodilator therapy

Dheyaa Alkhanfar - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic thromboembolic pulmonary hypertension

N/A

CIPHER: a prospective, multicentre study for the identification of biomarker signatures for early detection of pulmonary hypertension

Luke Howard - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic thromboembolic pulmonary hypertension

N/A

Plasma metabolomics in chronic thromboembolic pulmonary hypertension

Emilia Świetlik - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic thromboembolic pulmonary hypertension

N/A

Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension

Robert A Lewis - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary arterial hypertension

N/A

Impact of borderline (BL pulmonary hypertension (PH in chronic lung diseases (CLD

Lucilla Piccari - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

The effects of oral corticosteroid treatment (OCS on sequential lung function tests in a cohort of patients with acute hypersensitivity pneumonitis (AHP

Abhinav Tiwari - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Extrinsic allergic alveolitis

N/A

Effects of nintedanib in patients with SSc-ILD and preserved and highly impaired lung function

Wim A Wuyts - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Nintedanib

Incident Depression in Patients with Chronic Obstructive Pulmonary Disease: a UK Population-based Study

Rayan Siraj - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Management of chronic breathlessness: a multinational survey of respiratory medicine and palliative care doctors

Małgorzata Krajnik - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Lung Cancer

N/A

Changes in SPPB during hospital admission for AECOPD

Hamish Mcauley - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved